Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Lemaitre Vascular (LMAT) Leases (2019 - 2025)

Lemaitre Vascular (LMAT) has disclosed Leases for 7 consecutive years, with $15.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 6.0% to $15.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.8 million, a 6.0% decrease, with the full-year FY2025 number at $15.8 million, down 6.0% from a year prior.
  • Leases was $15.8 million for Q4 2025 at Lemaitre Vascular, down from $16.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $18.0 million in Q4 2023 to a low of $14.7 million in Q1 2022.
  • A 5-year average of $16.2 million and a median of $15.9 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: rose 15.31% in 2023, then decreased 8.78% in 2025.
  • Lemaitre Vascular's Leases stood at $15.1 million in 2021, then increased by 3.74% to $15.6 million in 2022, then rose by 15.31% to $18.0 million in 2023, then dropped by 6.98% to $16.8 million in 2024, then decreased by 6.0% to $15.8 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Leases are $15.8 million (Q4 2025), $16.0 million (Q3 2025), and $16.5 million (Q2 2025).